35th Annual Report for FY 2025-26 filed; AGM set for Sep 29

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹13.63

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.2% vs market

Trading & Distributors peers, median of 140sector-0.1%+0.7% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.7 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7+0.4+0.2-0.1+0.7

Next day

+5.6+0.9+4.7-0.2+5.9

+10.9+0.8+10.1-1.0+11.9

+16.4+0.6+15.8-1.2+17.6

+11.7+0.7+11.0-1.4+13.1

+17.2-2.6+19.8-2.6+19.8

+29.1-1.9+31.0-2.5+31.6

15d

+32.4-0.6+33.0-4.1+36.5

+14.3-1.0+15.3-4.4+18.8

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 140Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Norris Medicines filed its 35th Annual Report for FY 2025-26 with BSE. AGM is on September 29, 2026 at 2:30 PM via video conferencing. Key items: reappoint Praveen Bafna as director, appoint Vimal Shah as Managing Director for 3 years at salary up to Rs 24 lakh per year, raise borrowing limit to Rs 50 crore, allow sale or lease of undertaking up to Rs 50 crore, and raise investment and loan limit to Rs 50 crore. One independent director resigned in December 2025.

Likely market impact

Enhanced borrowing and disposal powers to Rs 50 crore hint at possible expansion or restructuring. MD reappointment gives leadership continuity.